iRhythm Technologies Investor Presentation August 2023

iRhythm Technologies presents its corporate overview as a leader in ambulatory cardiac monitoring with approximately 28% penetration in the core U.S. market, serving 6+ million patients globally across 66 countries. The company highlights over 1.5 billion hours of curated ECG data, 35+ peer-reviewed publications, and strong revenue growth exceeding 30% annually over five years with 1.5 million patients served annually.